View in EDS

Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

Saved in:
Bibliographic Details
Title: Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.
Authors: Siu DHW; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; Department of Medical Oncology, Illawarra Cancer Care Centre, Wollongong, NSW, Australia., Lin FPY; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, Australia., Thomas DM; Centre for Molecular Oncology, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Thavaneswaran S; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, Australia.; The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, Australia., Espinoza D; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia., Chinchen S; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia., Ballinger ML; Centre for Molecular Oncology, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Simes RJ; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia., Lee CK; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia.
Source: Future oncology (London, England) [Future Oncol] 2026 Jul; Vol. 22 (16), pp. 1965-1974. Date of Electronic Publication: 2026 Jun 16.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42299695
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Siu+DHW%22">Siu DHW</searchLink>; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; Department of Medical Oncology, Illawarra Cancer Care Centre, Wollongong, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Lin+FPY%22">Lin FPY</searchLink>; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Thomas+DM%22">Thomas DM</searchLink>; Centre for Molecular Oncology, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Thavaneswaran+S%22">Thavaneswaran S</searchLink>; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, Australia.; The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Espinoza+D%22">Espinoza D</searchLink>; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Chinchen+S%22">Chinchen S</searchLink>; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Ballinger+ML%22">Ballinger ML</searchLink>; Centre for Molecular Oncology, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Simes+RJ%22">Simes RJ</searchLink>; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+CK%22">Lee CK</searchLink>; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.; Cancer Care Centre, St George Hospital, Kogarah, NSW, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2026 Jul; Vol. 22 (16), pp. 1965-1974. <i>Date of Electronic Publication: </i>2026 Jun 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42299695
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14796694.2026.2688570
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1965
    Titles:
      – TitleFull: Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Siu DHW
      – PersonEntity:
          Name:
            NameFull: Lin FPY
      – PersonEntity:
          Name:
            NameFull: Thomas DM
      – PersonEntity:
          Name:
            NameFull: Thavaneswaran S
      – PersonEntity:
          Name:
            NameFull: Espinoza D
      – PersonEntity:
          Name:
            NameFull: Chinchen S
      – PersonEntity:
          Name:
            NameFull: Ballinger ML
      – PersonEntity:
          Name:
            NameFull: Simes RJ
      – PersonEntity:
          Name:
            NameFull: Lee CK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1